Clinical Trials on EGF-R Positive Non-Small Cell Lung Cancer in Poland
Total 812 results
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
Independent Public Care Health Facility of the...UnknownNon-small Cell Lung CancerPoland
-
Oncozyme Pharma Inc.CompletedNon-small Cell Lung CancerPoland
-
Pulmonary Hospital ZakopaneCompletedNon-small Cell Lung CancerPoland
-
Daiichi SankyoActive, not recruitingEGFR L858R | EGFR Exon 19 Deletion | Nonsquamous Non-small Cell Lung CancerKorea, Republic of, United States, Netherlands, Spain, United Kingdom, Japan, Austria, Belgium, Italy, France, Taiwan, Germany, Australia, Singapore, China, Hong Kong, Norway, Canada, Poland, Portugal, Switzerland
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
Pulmonary Hospital ZakopaneRecruitingNon-Small Cell Lung Cancer (NSCLC) | Video Assisted Thoracic Surgery (VATS)Poland
-
BIND TherapeuticsCompletedSquamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung CancerUnited States, Russian Federation
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
Xiuning LeM.D. Anderson Cancer Center; Eli Lilly and CompanyActive, not recruitingNon Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | EGFR Gene MutationUnited States
-
ArriVent BioPharma, Inc.Allist Pharmaceuticals, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | EGFR Exon 20 MutationsUnited States, Australia, Spain, France, Italy, China, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Singapore, Taiwan, Thailand, Brazil, Israel, United Kingdom
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownNon Small Cell Lung Cancer (NSCLC) | Intrathoracic Nodal StagingNetherlands, Poland
-
Cullinan Therapeutics Inc.RecruitingNon Small Cell Lung Cancer | EGFR Exon 20 MutationUnited States, Taiwan, Spain, Korea, Republic of, Japan, Singapore, Italy, Netherlands, Hong Kong
-
ArdigenMałopolskie Centre of EntrepreneurshipUnknownNon Small Cell Lung Cancer | Immunotherapy | Neoantigens | Neoepitopes | Next Generation Sequencing (NGS) | Personalized Neoantigen Cancer VaccinePoland
-
OHSU Knight Cancer InstituteAstraZeneca; Oregon Health and Science UniversityCompletedStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
BayerRecruitingAdvanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationHong Kong, United States, Taiwan, Spain, Belgium, China, Japan, France, Korea, Republic of, Singapore, Poland, Israel, Italy, Netherlands, Portugal, Brazil
-
Providence Health & ServicesNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationCompletedNon Small Cell Lung CancerUnited States
-
Providence Health & ServicesBristol-Myers Squibb; Genentech, Inc.TerminatedNon-squamous Non-small Cell Lung CancerUnited States
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVUnited States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
-
Medical University of GdanskPharmacia; Central and Eastern European Oncology Group; Stowarzyszenie Ludzi...Suspended
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLCUnknownNon Small Cell Lung CancerNetherlands
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIKorea, Republic of, Poland, Spain, Turkey
-
Erasmus Medical CenterRecruiting
-
Erasmus Medical CenterRecruitingNon-small Cell Lung CancerNetherlands
-
Brown UniversityBristol-Myers SquibbRecruitingNon Small Cell Lung CancerUnited States
-
Helix BioPharma CorporationPharm-Olam InternationalCompletedNon-Small Cell Lung CancerPoland
-
Academisch Ziekenhuis MaastrichtThe Netherlands Cancer Institute; ZonMw: The Netherlands Organisation for Health...Completed
-
Brown UniversityLifespanActive, not recruitingStage III Non-small-cell Lung CancerUnited States
-
Heat BiologicsCompletedNon-small Cell Lung CancerUnited States
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)Poland
-
Cancer Research and Biostatistics Clinical Trials...Novartis Pharmaceuticals; University of Arizona; Providence Cancer Center, Earle...CompletedNon Small Cell Lung CancerUnited States
-
UCB PharmaCompletedCarcinoma | Non-Squamous Non-Small-Cell Lung CancerPoland, Russian Federation, Hungary
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland
-
AstraZenecaCompletedNon-small Cell Lung CancerItaly, Poland, France, Spain, United States, Russian Federation
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung CancerSpain, Italy, Poland, Brazil, Turkey, Serbia, France, Korea, Republic of, Romania, Hungary, Russian Federation, United States, United Kingdom, Germany, Greece, Japan, Thailand, Ukraine, China
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingStage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | ALK Gene Rearrangement | ALK Gene Translocation | ALK...United States, Guam, Puerto Rico
-
Maria Sklodowska-Curie National Research Institute...Medical University of Gdansk; The Greater Poland Cancer Centre; Medical University... and other collaboratorsCompletedNon-Small Cell Lung CancerPoland
-
MedImmune LLCTerminatedNon-small Cell Lung CancerUnited States, Canada, Japan, Poland, Germany, Hungary, France
-
NewLink Genetics CorporationTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Recurrent | Progression of Non-small Cell Lung CancerUnited States
-
Central European Cooperative Oncology GroupTerminatedNon-Small Cell Lung CancerAustria, Hungary, Poland
-
NeoImmuneTechRoche Pharma AGActive, not recruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small Cell Lung CarcinomaUnited States
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small Cell | Non-Small-Cell Lung CancerUnited States, Canada, Poland
-
Taiho Oncology, Inc.CompletedAdvanced or Metastatic Non-small Cell Lung CancerUnited States, France, Poland, Spain, Italy, Japan
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lunch CancerItaly, United States, Germany, Spain, Canada
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingStage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
GenmabTerminatedNon Small Cell Lung CancerBelgium, United States, France, Netherlands, United Kingdom